ArticleInfection2016

Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C.

Ilaria Izzo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.